Genome editing allows scientists to change an organism's DNA. One promising genome editing protocol, already validated in living organisms, is based on clustered regularly interspaced short palindromic repeats (CRISPR)/Cas protein-nucleic acid complexes. When the CRISPR/Cas approach was first demonstrated in 2012, its advantages with respect to previously available techniques, such as zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), immediately got attention and the method has seen a surge of experimental and computational investigations since then. However, the molecular mechanisms involved in target DNA recognition and cleavage are still not completely resolved and need further attention. The large size and complex nature of CRISPR/Cas9 complexes has been a challenge for computational studies, but some seed results exist and are illuminating on the cleavage activity. In this short review, we present recent progress in studying CRISPR/Cas9 systems by molecular dynamics simulations with coarse-grained and atomistic descriptions, including enhanced sampling.
Introduction
During the Second International Summit on Human Genome Editing in Hong Kong, He Jiankui of the Southern University of Science and Technology (SUST) in Shenzhen, China, announced that a set of twin girls were brought into the world after applying the CRISPR/Cas9 genome editing technique. The girls were born to an HIV-negative mother and an HIV-positive father. He Jiankui reported that the mother was impregnated with embryos modified by CRISPR/Cas9 facilitated knockdown of chemokine receptor (CCR5), making the embryos resistant to HIV infection (1) . This is a clear evidence of the huge potential impact of genome editing in human life.
Nearly two decades ago, the paper titled 'Initial sequencing and analysis of the human genome' (2) was published and considered to be a major milestone in the international Human Genome Project. Ever since, human genetics has become the focus of biomedical research and therapeutics. By definition, a genome is an organism's complete set of DNA, which is composed of DNA bases in stacked pairs. The process of accurately changing the DNA bases at predetermined locations is genome editing. The ability to intentionally precisely modify the genetic code is highly valuable and it is the objective of intense research efforts. There currently exist different plausible molecular techniques, of which CRISPR/Cas is the most promising one.
In this short review, after tracing the history of the CRISPR/Cas technique and describing the structure of the molecular complexes, we focus on computational studies of the system, which nicely complement experimental work in the field. Cas is the short name for "CRISPR-associated protein"; there are different such proteins and Cas9, CRISPR-associated protein 9, is one of them.
Historical Background
Genome editing techniques like transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs) and CRISPR/Cas have already enabled researchers to make precise modifications at the nucleotide level. In ZFNs and TALENs, the DNA sequence is recognized by a protein: thus, different protein mutants need to be engineered for different target sequences. In CRISPR/Cas, instead, there is no need for lengthy protein engineering, because the target DNA sequence is recognized by a complementary RNA sequence bound to an endonuclease protein.
The CRISPR/Cas method offers a number of other advantages over TALENs and ZFNs: it is easily programmable, inexpensive and efficient. The CRISPR/Cas timeline (Figure 1) is intriguing. It includes results starting from 1987, when the CRISPR cluster repeats were reported for the first time (3). However, it was much later, in August 2012, that Emmanuelle Charpentier, in collaboration with Jennifer Doudna at the University of California Berkeley, demonstrated the use of CRISPR/Cas9 to target and cleave five specific genomic sites of the gene encoding the green fluorescent protein (GFP) (4): they generalized their conclusions to potentially any target DNA sequence. Further significant progress was achieved slightly after, in February 2013, when Feng Zhang of the Broad Institute of MIT and Harvard in Cambridge, MA, reported the use of CRISPR/Cas9 for editing genomes of cultured mouse cells and human cells (5) . In 2014 the first crystal structures of CRISPR/Cas9 (6, 7) complexes were made available in the Protein Data Bank. CRISPR/Cas is now a very fast-moving field of research, with more than 17000 reports available in 2018. 
The Natural Origin of the CRISPR/Cas technique
Viruses have been a common threat to the survival of bacteria and archaea. As a result of this battle between predator and prey, an array of countermeasures has been adopted by the host organism. The CRISPR system is one such highly adaptive and inheritable bacterial defense mechanism (8) (Figure 2) . When a bacterium is infected by a virus and overcomes the infection, it archives fragments of the viral genome, as a memory of the infection. The viral sequences are integrated into the bacterial DNA and intercalated by short repeating elements. The modified bacterial DNA is translated into single strands of RNA that, anchored to suitable proteins, scan new infecting viruses, which are immediately neutralized if the previous infection is recognized through DNA-RNA complementarity. This CRISPR/Cas technique requires the presence of a set of CRISPR-associated (cas) genes (9) and acts in three stages: (i) adaptation, e.g., insertion of new spacers in CRISPR locus, (ii) expression, e.g., transcription of CRISPR RNA (crRNA) and (iii) interference, e.g., recognition and destruction of target DNA sequences (9, 10). Figure 2 : CRISPR/Cas9-mediated acquired immunity in prokaryotes. During the acquisition phase (A), cellular invaders such as phage viruses inject nucleic acid sequences into the host cell. After infection, novel DNA sequences from the cellular invaders are incorporated into the host CRIPSPR locus as spacers (colored circles) flanked by repeat sequences (gray diamonds). As a result, when the CRISPR locus is transcribed, the pre-CRISPR RNAs (crRNAs) encode the newly acquired protospacer sequences. The pre-crRNA is cleaved to produce individual crRNAs that will associate with Cas proteins. The Cas protein utilizes the crRNAs as guides to silence foreign DNA that matches the crRNA sequence (B, interference phase). As a result, the second time a bacterium encounters the same foreign DNA, the crRNA/Cas9 complex is able to identify and silence the DNA. From Ref (11) with permission.
CRISPR/Cas Classification
The absence of a universal cas gene and its fast evolution (12) has made classification of CRISPR/Cas systems difficult. Hence, multi-level classification is adopted, wherein the CRISPR/Cas systems are broadly classified into two classes, and further subdivided into six types and 33 subtypes (13) (14) (15) . The difference between the two classes is that the Class 1 systems have multi-subunit effector complexes and in Class 2 systems all functions are performed by a single protein effector module (16) . Class 1 includes type I, type III and type IV systems. Class 2 includes the well-known type II systems (including Cas9 and Cpf1), and much more rare type V and type VI systems (14) . The classification criteria for classes and types are: a fundamental difference in the organization of the effector modules between two classes; unique signature genes for each of the types. The classification of subtypes is more complex: for certain subtypes, the signature genes are readily defined, while for other subtypes the signature genes are defined through comparison of conserved genes and locus organization (17) .
CRISPR/Cas9 Structure
In this review we focus on the most popular Class 2 CRISPR/Cas system with the CRISPRassociated protein 9 (Cas9) derived from type II-A CRISPR, obtained from Streptococcus pyogenes -spCas9. The CRISPR/Cas9 system is a complex composed of single guide RNA (sgRNA) and a 160kDa DNA endonuclease enzyme, Cas9 (18) , which cuts each strand of doublestranded DNA at a specific location, through its nuclease domains.
The sgRNA-bound Cas9 endonuclease binds to a double-stranded DNA (dsDNA) upon site-specific recognition of a short trinucleotide Protospacer Adjacent Motif (PAM) within the DNA (19) . Thereafter, the target DNA (tDNA) strand, which is complementary to the first 20 nucleotides (-nt) of the sgRNA, forms an RNA-DNA hybrid duplex displacing the non-target DNA (ntDNA) strand from the dsDNA (20) . The sgRNA ( Figure 3 ) is composed of two noncoding RNA components fused together: a CRISPR RNA (crRNA) that confers target specificity to Cas9 and a transactivating CRISPR RNA (tracrRNA) that can bind to Cas9 (21, 22) . The crRNA contains the 20-nt long 'spacer' or 'guide' sequence at the 5'-end that forms the RNA-DNA hybrid, and a 'repeat' sequence at the 3'-end that forms a duplex with the tracrRNA (18, 23, 24) . Since the crRNA cannot bind to Cas9 alone, it complexes with the tracrRNA and the resultant RNA:RNA duplex fits into Cas9 (22, 25) . A sgRNA can be synthetically generated or obtained in vitro or in vivo from a DNA template.
The Cas9 endonuclease ( Figure 4 ) has two lobes: recognition (REC) lobe and nuclease (NUC) lobe, connected by an Arginine-rich linker. The REC (residues 56-718) and NUC (residues 1-55 and 719-1368) lobes are responsible for association with the sgRNA (7) and cleavage of the DNA, respectively. The NUC lobe consists of different domains: RuvC (residues 1-55, 719-765, and 919-1099), HNH (residues 780-906), and PAM-interacting (PI) (residues 1100-1368) (7, (26) (27) (28) . The RNA-DNA hybrid duplex, with a negatively charged backbone, is accommodated at the positively charged groove formed between REC and NUC lobes (7) . The unwound ntDNA (u-ntDNA) strand is proposed to be hosted, before cleavage, at the HNH/RuvC boundary, through stabilizing electrostatic interactions between the negatively charged backbone of u-ntDNA and the positively charged amino acids of the HNH and RuvC domains (29) . The HNH and RuvC domains perform site-specific cleavages of the tDNA and ntDNA strands (30) , respectively, resulting in a double-strand break (DSB), thereby inducing the host DNA repair mechanisms (20) . Figure 3 : Scheme of the nucleic acid sequence/folding in a CRISPR/Cas9 ternary complex (protein + RNA + DNA) after the Cas9-RNA complex binds to a target DNA. The u-ntDNA strand is absent or short in available crystal structures, including PDB ID 4UN3 (27) . In this image, it is elongated according to an electrostatic interaction hypothesis (31) . The PAM is highlighted in yellow and numbering of u-ntDNA strand is shown with nucleotides +1 to +16 upstream of PAM. The entire ntDNA strand can be conveniently divided into three segments: PAM duplex, nucleotides -1 to -8; PAM-proximal, nucleotides +1 to +8; PAM-distal, nucleotides +12 to +16. (31) . The protein is represented with transparent surfaces, the nucleic acids are represented as cartoons, using the visualization software VMD (32) .
Molecular Mechanism of CRISPR/Cas9
Crystal structures of SpCas9-sgRNA bound to dsDNA (27, 28) have aided the understanding of the molecular mechanism of Cas9-catalyzed DNA cleavage. Site-specific DNA recognition and cleavage is achieved after Cas9, in complex with guide RNA (crRNA-tracrRNA complex or sgRNA), binds to a target DNA sequence. Thus, as the first step of genome editing by CRISPR/Cas9, the Cas9 protein makes extensive interactions with the sgRNA. Specifically, the crRNA:tracrRNA duplex and stem loop 1 of the sgRNA (Figure 3 ) are crucial for Cas9-RNA complex formation (33); stem loops 2 and 3 may play a role in increasing catalytic efficiency in vivo (5, 7, 33, 34) . The Cas9-RNA complex then searches for the complementary target DNA sequence, by probing for the PAM (19) , highlighted in yellow in Figure 3 . The PAM sequence is protein-dependent; for SpCas9, it is 5'-NGG-3', where N can be any DNA base (A, T, G, C). The PAM sequence must be found adjacent to the cleavage site in the ntDNA strand. The GG dinucleotide of the PAM in the ntDNA strand is read out via major groove interactions with conserved Arginine residues (R1333 and R1335) of the C-terminal domain (CTD in Figure 4 ) of Cas9, also called PAM-interacting (PI) domain. The PI domain of Cas9 also makes contacts with the minor groove of PAM-containing duplex. The residues S1136 and K1107 interact with nucleotides of ntDNA and tDNA strands, respectively, through water-mediated H-bonding. Thus, PAM binding is mainly governed by major groove base recognition, but minor groove interactions between the PAM and Cas9 orient the tDNA strand for base pairing with sgRNA (27) . After unwinding of the target DNA, the tDNA strand is stabilized by a "phosphate lock loop", wherein the phosphate group immediately upstream of the PAM is stabilized by amide groups of residues K1107-E1108-S1109 (27) .
In a nutshell, local DNA melting is triggered at the PAM-adjacent nucleation site, followed by formation of an "R-loop structure" by the RNA-DNA hybrid duplex and the u-ntDNA strand.
Complementary base pairing between the 20-nt long spacer RNA sequence and the tDNA strand is necessary for such target binding specificity and cleavage (18) . Upon PAM recognition and subsequent R-loop formation, the Cas9 enzyme is activated for DNA cleavage. The HNH and RuvC domains cleave the tDNA and ntDNA strands, respectively, at a specific site 3 base pairs upstream of the NGG PAM sequence, producing a predominantly blunt-ended DSB (18) . In 2016, Zuo and Liu argued, on the basis of MD trajectories, that Cas9-catalyzed DNA cleavage can lead to 1-bp staggered ends, as opposed to blunt ends (35) ; while the possibility of obtaining staggered ends by Cas9 cleavage is still questionable and needs further evidence, such a cleavage product would be conducive to better homologous recombination strategies.
Another relevant aspect of Cas9 action is that the protein cleaves the target DNA duplex in the presence of divalent metal ions, as HNH and RuvC are Mg 2+ -dependent nuclease domains (36, 37) . The RuvC domain has a typical RNase-H fold structure containing four functionally essential residues, D10, E762, H983, and D986, which require a two-metal-ion catalysis mechanism for editing (36) (37) (38) . The HNH domain, on the other hand, has a ββα-metal fold with three catalytic residues, D839, H840 and N863, consistent with a one-metal-ion cleavage mechanism (36) (37) (38) .
During MD simulations of CRISPR/Cas9 system in the presence of Mg 2+ ions, the tDNA and ntDNA strands stabilize near the HNH and RuvC catalytic sites, respectively (30) . However, currently available force fields for magnesium ions have limitations. Thus, the mechanistic details of how the catalytic Mg 2+ ions meditate the concerted DNA strand cleavage by two domains of Cas9 are still elusive. (20) . The results of these computational experiments showed that the catalytic site H840 of the HNH domain is found at a distance of 25 Å from the scissile phosphate of the tDNA strand in the absence of ntDNA, incompatible with cleavage activity. The same work reported that instead, in the presence of ntDNA, H840 stabilizes at a smaller distance of 15 Å from the scissile phosphate of the tDNA strand ( Figure 5 ). It may seem that the distance of 15 Å is still too large for catalytic activity. Still, the authors pointed out that in the initial structure the same distance was 18 Å; hence, during the MD run the distance decreased to 15 Å in the presence of the ntDNA strand. This conformation is suggested to stabilize the H840 catalytic site of HNH domain at a distance of ~15 Å from the scissile phosphate on the tDNA strand, and cleavage of the tDNA strand by H840 follows. The communication between the RuvC domain and the ntDNA strand that influences the HNH catalytic domain positioning has been termed "crosstalk" between HNH and RuvC domains, which is dependent on the interactions between the hinge region and ntDNA strand (43) . Thus, we now believe that the arrangement of the u-ntDNA strand in the complex is crucial for DNA editing. Another important aspect that was described in the same work (43) is that, in order for the ntDNA to bind the RuvC domain, it is important for the HNH domain to reposition, which is possible because the HNH domain has an inherent conformational plasticity, as revealed interact with K775 and R905, respectively, forming essential edges of the allosteric pathway.
MD Simulations of CRISPR/Cas9 complexes
These interactions connect HNH to RuvC and the α-helical lobe via the linkers LI and LII, which effectively function as "allosteric transducers" (28, 45) . The optimal path for information flow was identified through the LI loop, via residues K772 and T770. Understanding the catalytic mechanism involved in accurate editing by CRISPR/Cas9 is particularly important, but it has been poorly addressed so far, due to uncertainties in the available crystal structures of Cas9. Recently, Yoon et. al. (48) attempted to analyze the catalytic mechanism and the energetics for the activation of Cas9, by using the empirical valence-bond (EVB) method.
Yoon and co-workers specifically looked for the catalytic roles of two positive residues K848 and K855 in the HNH domain. They found that the catalytic state most likely involves a structure where K848 comes close to the scissile phosphate of tDNA strand.
The computational work discussed above was dedicated to understanding the structure, The CRISPR/Cas9 approach has been exploited for efficient genome editing in a wide variety of organisms. However, the method exhibits a major undesired effect: it results in unwanted editing at off-target sites that are similar to on-target DNA sequences (50, 51) . It is important to make progress towards eliminating such off-target effects on a genome-wide scale. Within the framework of the hypothesis proposed for Cas9-sgRNA (29, 50) , the structural information In addition to dynamics of wild-type SpCas9, the dynamics of a high fidelity Cas9 mutant has also been explored using MD simulations for understanding off-target effects. Zheng et. al. The issue of specificity is also currently addressed in our group, by MD simulations of CRISPR/Cas9 complexes with protein mutations at the HNH/RuvC boundary. Our work is inspired by the suggestion, based on experimental data (29) , that attractive electrostatic interactions between positive protein residues at this boundary and the negative backbone of the u-ntDNA strand keep the u-ntDNA strand unwounded (Figure 8) , Attention has been mostly focused on the HNH and RuvC domains, as these compose the catalytic region and contain the nuclease active site, with very little work on the REC lobe. We anticipate the need for large amounts of experimental and theoretical/computational work to explore other parts of the protein, which may play crucial allosteric roles in nucleic acid recognition and cleavage. exploited more extensive comprehension of structural design will eventually enable scientists to tailor specific Cas9 variants with no off-target effects. Figure 8 : Scheme of various competitive interactions in the system.protein-ntDNA, t-DNA-ntDNA, tDNA-RNA. If the protein-ntDNA interaction strength is decreased by mutating charged Cas9 residues to neutral residues, there will be a driving force towards DNA duplex re-hybridization, unless the hybrid RNA:tDNA duplex is very strong, which is the case for perfect complementarity.
Limitations and Future Directions
The nuclease activity of Cas9 can be triggered even when there is imperfect complementarity between the sgRNA and an off-target genomic site, particularly if mismatches are distal to PAM (27, 51, 55) . where the u-ntDNA strand is hosted, could weaken the ntDNA strand binding to protein ( Figure   Figure 9 : Left: scheme of the experimental system for EPR measurements. Center: Measured distance profiles for selected DNA sites. Right: simulated structure, with the elongated ntDNA in black and the sites for distance calculations visualized as spheres. From Ref (31) with permission.
8).
This would encourage re-hydridization between the tDNA and ntDNA strands, causing "Rloop collapse". Hence, a more stringent Watson-Crick base pairing between guide RNA and target DNA would be necessary to prevent the R-loop collapse. Slaymaker et. al. (29) initially generated thirty-one SpCas9 mutants replacing charged amino acids at the HNH/RuvC interface with alanine. The top five specificity conferring mutants were R780A, K810A, K848A, K855A
and H982A. We are currently performing µs-long MD simulations to investigate the structural and dynamical basis of this intriguing hypothesis. Specifically, we are addressing CRISPR/Cas9 ternary complexes with wild-type Cas9 and three Cas9 mutants: K855A, H982A and a combination K855A+H982A. We use the system derived from PDB ID 4UN3, with an elongated u-ntDNA strand (Figure 9 ) (31) and modeled missing Cas9 residues. Preliminary results (56) , obtained by the comparison between complexes with wild-type and mutated Cas9 complexes, yield structural insights into the active DNA-bound state of the RuvC domain, highlighting motions that are consistent with the competing electrostatic interactions as illustrated in Figure 8 . Our preliminary results concur with the hypothesis that protein mutations can be exploited to produce more specific CRISPR/Cas9 variants. 
